We are live on ! Find out more
ENTX icon

Entera Bio
ENTX

18 hedge funds and large institutions have $17.4M invested in Entera Bio in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

29% more funds holding

Funds holding: 14 → 18 (+4)

9% more capital invested

Capital invested by funds: $15.9M → $17.4M (+$1.48M)

4.14% more ownership

Funds ownership: 20.35% → 24.49% (+4.1%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.24%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
4
Increased
4
Reduced
3
Closed
–
Calls
$54K
Puts
–
Net Calls
+$54K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.87M
2
PHP
Parkman Healthcare Partners
Connecticut
+$56.4K
3
Bank of America
Bank of America
North Carolina
+$49.1K
4
TSS
Two Sigma Securities
New York
+$27.3K
5
XT
XTX Topco
Cayman Islands
+$23.6K

Top Sellers

Rank Fund Capital Flow
1
SSA
Schonfeld Strategic Advisors
New York
-$72.1K
2
Northern Trust
Northern Trust
Illinois
-$29.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$7.9K
Name Holding Trade Value Shares
Change 		Change in
Stake
KCM
1
Knoll Capital Management
Florida
$10M – – –
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$4.59M +$5.87M +2,697,236 New
SSA
3
Schonfeld Strategic Advisors
New York
$1.02M -$72.1K -33,155 -5%
PHP
4
Parkman Healthcare Partners
Connecticut
$747K +$56.4K +25,900 +6%
Northern Trust
5
Northern Trust
Illinois
$338K -$29.7K -13,652 -6%
PWM
6
Perigon Wealth Management
California
$248K – – –
Renaissance Technologies
7
Renaissance Technologies
New York
$108K +$3.26K +1,500 +2%
SEIA
8
Signature Estate & Investment Advisors
California
$80.5K – – –
Susquehanna International Group
9
Susquehanna International Group
Pennsylvania
$59.1K -$7.9K -3,633 -9%
Bank of America
10
Bank of America
North Carolina
$52.7K +$49.1K +22,557 +268%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$35.9K – – –
HighTower Advisors
12
HighTower Advisors
Illinois
$30.8K +$13.7K +6,310 +53%
TSS
13
Two Sigma Securities
New York
$21.3K +$27.3K +12,554 New
XT
14
XTX Topco
Cayman Islands
$18.5K +$23.6K +10,859 New
PNC Financial Services Group
15
PNC Financial Services Group
Pennsylvania
$17K – – –
NA
16
NewEdge Advisors
Louisiana
$15.3K – – –
CSS
17
Cubist Systematic Strategies
Connecticut
$2.65K +$3.39K +1,560 New
Group One Trading
18
Group One Trading
Illinois
$87 – – –

ENTX Hedge Fund Activity: Q1 2025 in Review

18 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Entera Bio (ENTX) for Q1 2025, worth a combined $17.4M — up 9.3% from $15.9M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ENTX positions and 0 closed out — a net gain of 4 holders — while 4 added to existing stakes and 3 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.87M. The largest seller was Schonfeld Strategic Advisors, cutting an estimated $72.1K.

  • 18 institutional investors held Entera Bio (ENTX) as of Q1 2025, up from 14 in Q4 2024.
  • Funds reported $17.4M of Entera Bio stock for Q1 2025, up 9.3% quarter-over-quarter.
  • 4 funds opened new Entera Bio positions in Q1 2025 and 0 closed out, a net change of +4 holders.
  • The largest Entera Bio buyer in Q1 2025 was Point72 Asset Management, an estimated $5.87M added.
  • The largest Entera Bio seller in Q1 2025 was Schonfeld Strategic Advisors, an estimated $72.1K sold.

Based on aggregated 13F filings for Q1 2025.